[Overdiagnosis in prostate cancer]

Christian Villeda1, Martha Olivia Gomez, Mariano Sotomayor

  • 1Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. México D.F. México.

Summary

Prostate cancer screening remains controversial. Over half of detected cases may be overdiagnosed, highlighting the need for active surveillance programs to manage risks associated with prostate cancer therapies.